2025
SJR Q2
JCR Q2 · 2,9
148 matched articles
SCIE
Journal detail
Fitoterapia
- Publisher
- Elsevier B.V.
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
0367326X18736971
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,511
- Quartile Q2
- H-Index 134
- Cites/doc 3,34
- Docs (3y) 950
- Cites (3y) 3.126
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,9
- 5Y JIF 2,9
- JCI 0,65
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Drug Discovery Q3
- Horticulture Q2
- Medicine (miscellaneous) Q3
- Pharmacology Q3
- Plant Science Q2
Areas
- Agricultural and Biological Sciences
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Chemistry, Medicinal | Pharmacology & Pharmacy | Integrative & Complementary Medicine
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,511 | 2,9 | 2,9 | 0,65 | Q2 | 134 |
| 2024 | Q2 | Q3 | 0,537 | 2,6 | 3 | 0,69 | Q2 | 130 |
| 2023 | Q2 | Q3 | 0,572 | 2,5 | 2,7 | 0,75 | Q2 | 130 |
| 2022 | Q2 | Q2 | 0,59 | 3,4 | 3,3 | 0,81 | Q2 | 130 |
| 2021 | Q2 | Q3 | 0,568 | 3,2 | 3,3 | 0,84 | Q2 | 130 |
| 2020 | Q2 | Q3 | 0,624 | 2,9 | 3,2 | 0,89 | Q2 | 130 |
| 2019 | Q2 | Q3 | 0,666 | 2,5 | 2,9 | 0,96 | Q2 | 130 |
| 2018 | — | Q3 | — | 2,4 | 2,9 | 0,96 | Q2 | — |
| 2017 | Q1 | Q2 | 0,937 | 2,6 | 2,9 | 0,99 | Q1 | 130 |
| 2016 | Q1 | Q2 | 0,937 | 2,7 | 2,9 | — | — | 130 |
| 2015 | Q2 | Q2 | 0,795 | 2,4 | 2,6 | — | — | 130 |
| 2014 | Q1 | Q3 | 0,897 | 2,3 | 2,5 | — | — | 130 |
| 2013 | Q1 | Q2 | 0,882 | 2,2 | 2,3 | — | — | 130 |
| 2012 | Q2 | Q2 | 0,791 | 2,2 | 2,1 | — | — | 130 |
| 2011 | Q2 | Q3 | 0,585 | 1,8 | 2 | — | — | 130 |
| 2010 | Q2 | Q2 | 0,631 | 1,9 | 1,9 | — | — | 130 |
| 2009 | — | Q3 | — | 1,4 | 1,7 | — | — | — |
| 2008 | — | Q3 | — | 1,2 | 1,5 | — | — | — |
| 2007 | — | Q3 | — | 1,1 | 1,6 | — | — | — |
| 2006 | — | Q4 | — | 0,9 | — | — | — | — |
| 2005 | — | Q4 | — | 0,8 | — | — | — | — |
| 2004 | — | Q3 | — | 1 | — | — | — | — |
| 2003 | — | Q3 | — | 0,8 | — | — | — | — |
| 2002 | — | Q4 | — | 0,6 | — | — | — | — |
| 2001 | — | Q4 | — | 0,5 | — | — | — | — |
| 2000 | — | Q4 | — | 0,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 46/72 |
| 2025 | INTEGRATIVE & COMPLEMENTARY MEDICINE | SCIE | Q2 | Q2 | 18/48 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 173/356 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 48/72 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 177/352 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q2 | 47/72 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 180/354 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q2 | 33/60 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 125/278 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q2 | 39/63 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 166/279 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q2 | 39/62 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 172/276 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q2 | 38/61 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 152/271 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q2 | 34/61 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 147/267 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 29/59 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 125/261 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 27/60 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 115/257 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 33/59 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 124/255 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 31/59 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 130/255 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 34/58 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 127/256 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 32/59 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 128/261 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 33/59 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 150/261 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 24/54 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 147/252 |
| 2009 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 32/46 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 173/237 |
| 2008 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 28/41 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 170/219 |
| 2007 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 28/41 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 159/205 |
| 2006 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 27/35 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 163/199 |
| 2005 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 26/34 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 160/193 |
| 2004 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 25/36 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 140/187 |
| 2003 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 26/37 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 142/185 |
| 2002 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 32/35 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 159/188 |
| 2001 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 36/36 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 169/186 |
| 2000 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 34/35 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 175/181 |